drugset / Trial / NCT04636567
Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery
NaSingle-groupOpen-labelDiagnostic
Summary
Phase 2, multicenter, efficacy and safety study evaluating the use of nerindocianine for the delineation of abdominopelvic ureter anatomy via near infrared fluorescence imaging during minimally invasive lower abdominal surgery (e.g. gynecological, lower gastrointestinal, or other lower abdominal surgery).
Timeline
- Start
- 2021-03
- Primary completion
- 2021-07
- Completion
- 2021-12
Outcome
Outcome not reported
Stopped (Business): “Clinical program has been suspended for business reasons.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nerindocianine | Diagnostic / imaging agent | 0.055 mg/kg | Intravenous |